|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation, amortization and accretion | |||||
| Amortization of financing costs | |||||
| Amortization of debt discount/premium, net | |||||
| Amortization of power purchase agreements, net | |||||
| Impairment expense | |||||
| Loss on derivatives | |||||
| Stock-based compensation | |||||
| Deferred taxes | |||||
| Intraperiod tax allocation | |||||
| Earnings in unconsolidated investments, net | |||||
| Distribution from unconsolidated investments | |||||
| Distributions from unconsolidated investments | |||||
| Gain on transactions | |||||
| Early extinguishment of debt | |||||
| Other reconciling items | |||||
| Changes in operating assets and liabilities: | |||||
| Counterparty collateral asset | |||||
| Trade receivables | |||||
| Prepaid expenses | |||||
| Other current assets | |||||
| Other assets (non-current) | |||||
| Accounts payable and other accrued liabilities | |||||
| Counterparty collateral liability | |||||
| Accrued interest | |||||
| Contract liability | |||||
| Other current liabilities | |||||
| Other long-term liabilities | |||||
| Contingent liabilities | |||||
| Derivatives | |||||
| Net cash provided by operating activities | |||||
| Contingent liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Cash paid for acquisitions and investments, net of cash and restricted cash acquired | |||||
| Proceeds from sale of investments, net of cash and restricted cash distributed | |||||
| Capital expenditures | |||||
| Distributions from unconsolidated investments | |||||
| Investment in Pattern Development 2.0 | |||||
| Other investing activities | |||||
| Other assets | |||||
| Issuance of notes receivable | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Proceeds from public offering, net of issuance costs | |||||
| Proceeds from issuance of convertible senior notes, net of issuance costs | |||||
| Proceeds from preferred share offering | |||||
| Dividends paid | |||||
| Buyout of noncontrolling interest | |||||
| Preferred share issuance costs | |||||
| Capital contributions - noncontrolling interests | |||||
| Capital distributions - noncontrolling interests | |||||
| Refund of deposit for letters of credit | |||||
| Payment for financing fees | |||||
| Proceeds from construction loans | |||||
| Proceeds from short-term debt | |||||
| Repayment of short-term debt | |||||
| Proceeds from long-term debt and other | |||||
| Repayment of long-term debt and other | |||||
| Payment for interest rate derivatives | |||||
| Cash paid for contingent consideration | |||||
| Proceeds (payments) for termination of designated derivatives | |||||
| Disposition of controlling interest, net | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosures | |||||
| Cash payments for income taxes | |||||
| Cash payments for interest expense | |||||
| Schedule of non-cash activities | |||||
| Change in property, plant and equipment | |||||
| Change in additional paid-in capital | |||||
| Accrual of equity issuance costs | |||||
| Preferred share dividends declared | |||||
| Purchase consideration | |||||
Loading...